Cell-cycle arrests and p53 accumulation induced by geldanamycin in human ovarian tumour cells

Cancer Chemotherapy and Pharmacology

Volumn 37, Issue 5, 1996, Pages 423-428

  McIlwrath, A J ^a   Brunton, V G ^a   Brown, R ^a  

^a BEATSON INSTITUTE FOR CANCER RESEARCH   (United Kingdom)

Author keywords

Cell cycle arrest; Geldanamycin; Human ovarian tumour cells; P53 accumulation

Indexed keywords

GELDANAMYCIN; PROTEIN P53; ANTINEOPLASTIC ANTIBIOTIC; BENZOQUINONE DERIVATIVE; DNA; MACROCYCLIC LACTAM; QUINONE DERIVATIVE;

ARTICLE; CELL CYCLE S PHASE; CONTROLLED STUDY; DRUG CYTOTOXICITY; HUMAN; HUMAN CELL; OVARY CARCINOMA; PRIORITY JOURNAL; TUMOR CELL LINE; BIOSYNTHESIS; CELL CULTURE; CELL CYCLE; CELL SURVIVAL; DNA DAMAGE; DRUG EFFECT; FEMALE; FLOW CYTOMETRY; GENETIC TRANSFECTION; INTERPHASE; METABOLISM; OVARY TUMOR; PATHOLOGY; POLYACRYLAMIDE GEL ELECTROPHORESIS; SISTER CHROMATID EXCHANGE;

ANTIBIOTICS, ANTINEOPLASTIC; BENZOQUINONES; CELL CYCLE; CELL SURVIVAL; DNA DAMAGE; DNA, NEOPLASM; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FEMALE; FLOW CYTOMETRY; HUMANS; INTERPHASE; LACTAMS, MACROCYCLIC; OVARIAN NEOPLASMS; QUINONES; S PHASE; SISTER CHROMATID EXCHANGE; TRANSFECTION; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0029664590     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002800050407     Document Type: Article

References (27)

1. Baker SJ, Markowitz S, Fearon ER, Wilson JKV, Vogelstein B (1990) Suppression of human colorectal carcinoma cell growth by wild type p53. Science 249:912
2. Behrens BC, Hamilton TC, Masuda H, Grotzinger KR, Whang-Peng J, Lonie KG, Knutsen T, McKoy WM, Young RC, Ozols RF (1987) Characterisation of a cis-diamminedichloroplatinum II resistant human ovarian cancer cell line and its use in evaluation of platinum analogues. Cancer Res 47:414
3. Benchekroun MN, Schneider E, Safa AR, Townsend AJ, Sinha BK (1994) Mechanisms of resistance to ansamycin antibiotics in human breast cancer cell lines. Mol Pharmacol 46:677
4. Brown R, Clugston C, Burns P, Edlin A, Vasey P, Vojtesek B, Kaye SB (1993) Increased accumulation of p53 in cisplatin-resistant ovarian cell lines. Int J Cancer 55:678
5. Clarke AR, Purdie CA, Harrison DJ, Morris RG, Bird CC, Hooper ML, Wyllie AH (1993) Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature 362:849
6. Fritsche M, Haessler C, Brandner G (1993) Induction of nuclear accumulation of the tumour-suppressor protein p53 by DNA-damaging agents. Oncogene 8:307
7. Garcia R, Parikh NU, Saya H, Gallick GE (1991) Effect of herbimycin A on growth and pp60c-src activity in human colon tumour cell lines. Oncogene 6:1983
8. Girinsky T, Graeber TG, Tsai M, Giaccia AJ (1994) Effect of tyrosine kinase inhibitors on p53 protein induction in wild-type and human papillomavirus E6 expressing cells. Proc Am Assoc Cancer Res 35:642
9. Jacobson MD, Burne JF, Raff MC (1994) Programmed cell death and Bcl-2 protection in the absence of a nucleus. EMBO J 13:1899
10. Kastan MB, Onyekwere O, Sidransky D, Vogelstein B, Craig RW (1991) Participation of p53 protein in the cellular response to DNA damage. Cancer Res 51:6304
11. Kelland LR, Mistry P, Abel G, Loh SY, O'Neill CF, Murrer BA, Harrap KR (1992) Mechanism-related circumvention of acquired cis-diamminedichloroplatinum(II) resistance using two pairs of human ovarian carcinoma cell lines by ammine/amine platinum(IV) dicarboxylates. Cancer Res 52:3857
12. Khanna KK, Lavin MF (1993) Ionising radiation and UV induction of p53 protein by different pathways in ataxia-telangiectasia cells. Oncogene 8:3307
13. Kuerbitz SJ, Plunkett BS, Walsh WV, Kastan MB (1992) Wild-type p53 is a cell cycle checkpoint determinant following irradiation. Proc Natl Acad Sci USA 89:7491
14. Lin D, Shields MT, Ullrich SJ, Appella E, Mercer WE (1992) Growth arrest induced by wild-type p53 protein blocks cells prior to or near the restriction point in late G1 phase. Proc Natl Acad Sci USA 89:9210
15. Lowe SW, Ruley HE, Jacks T, Housman DE (1993) p53-Dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 74:957
16. McIlwrath AJ, Vasey PA, Ross GM, Brown R (1994) Cell cycle arrests and radiosensitivity of human tumour cell lines: dependence on wild-type p53 for radiosensitivity. Cancer Res 54:3718
17. Milner J, Medcalf EA, Cook AC (1991) Tumour suppressor p53 analysis of wild-type and mutant p53 complexes. Mol Cell Biol 11:12
18. Nelson WG, Kastan MB (1994) DNA strand breaks: the DNA template alterations that trigger p53-dependent-DNA damage response pathways. Mol Cell Biol 14:1815
19. O'Connor PM, Jackman J, Jondle D, Bhatia K, Magrath I, Kohn KW (1993) Role of the p53 tumour suppressor gene in cell cycle arrest and radiosensitivity of Burkitt's lymphoma cell lines. Cancer Res 53:4776
20. Perry P, Wolff S (1974) New Geimsa method for the differential staining of sister chromatids. Nature 251:156
21. Sherr CJ (1993) Mammalian G1 cyclins. Cell 73:1059
22. Takahashi K, Suzuki K, Uehara Y, Ono T (1995) Growth inhibition by anchorage deficiency is associated with increased level but reduced phosphorylation of mutant p53. Jpn J Cancer Res 83:358
23. Uehara Y, Hori M, Takeuchi T, Umezawa H (1985) Screening of agents which convert 'transformed morphology': identification of an active agent as herbimycin and its inhibition of intracellular src kinase. Jpn J Cancer Res 76:672
24. Uehara Y, Hori M, Takeuchi T, Umezawa H (1986) Phenotypic change from transformed to normal induced by benzoquinoid ansamycins accompanies inactivation of p60src in rat kidney cells infected with Rous sarcoma virus. Mol Cell Biol 6:2198
25. Uehara Y, Fukazawa H, Murakami Y, Mizuno S (1989) Irreversible inhibition of v-src tyrosine kinase activity by herbimycin A and its abrogation by sulfhydryl compounds. Biochem Biophys Res Commun 163:803
26. Wyke AW, Cushley W, Wyke JA (1993) Mitogenesis by v-src: a need for active oncoprotein both in leaving G0 and in completing G1 phases of the cell cycle. Cell Growth Differ 4:671
27. Yamaki H, Suzuki H, Choi EC (1982) Inhibition of DNA synthesis in murine tumour cells by geldanamycin, an antibiotic of the benzoquinoid ansamycin group. Antibiot 35:886